Biotest
Stephan Fleck currently serves as the VP of Corporate Controlling at Biotest AG, a position held since May 2002. Prior to this role, Stephan held various positions at Boehringer Ingelheim, including Projekt-Mitarbeiter from September 2001 to April 2002, VP Finance, Treasurer & Assistant Secretary at Boehringer Ingelheim Vetmedica Inc. USA from November 2000 to August 2001, and several key roles in controlling and consolidation from January 1988 to October 2000, which included Head of Controlling Technology and Manufacturing Pharma, Head of Group Consolidation and Costing, and Manager of Consolidation and Costing. Earlier in the career, from January 1984 to December 1987, Stephan worked at Boehringer Ingelheim Espana S.A. in Controlling und Reporting.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.